Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs.
D000380:Agranulocytosis / Q000188:drug therapy*; D000728:Androgens / Q000627:therapeutic use*; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D002066:Busulfan / Q000494:pharmacology; D002330:Carmustine / Q000009:adverse effects*; D002455:Cell Division / Q000187:drug effects; D002999:Clone Cells / Q000187:drug effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006098:Granulocytes / Q000187:drug effects; D006410:Hematopoiesis / Q000187:drug effects*; D051379:Mice; D009277:Nandrolone / Q000627:therapeutic use; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D010110:Oxymetholone / Q000627:therapeutic use; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D013268:Stimulation, Chemical; D013739:Testosterone / Q000627:therapeutic use; D014747:Vinblastine / Q000009:adverse effects*
D000728:Androgens; D013739:Testosterone; D014747:Vinblastine; D009277:Nandrolone; D003520:Cyclophosphamide; D002066:Busulfan; D010110:Oxymetholone; D002330:Carmustine